The 13 most recent market catalysts affecting $AMRZ, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 22, 2026
Corporate Catalyst
Bearish
Impact 65
UBS Maintains Neutral on Amrize, Lowers Price Target to $42
UBS analyst Julian Radlinger has revised their price target for Amrize (AMRZ) down to $42 from $57, while keeping a 'Neutral' rating. This substantial 26% reduction in the price ta…
Sep 18, 2026
Corporate Catalyst
Bearish
Impact 55
Oppenheimer Maintains Outperform on Amrize, Lowers Price Target to $55
Oppenheimer analyst Bryan Blair maintained an 'Outperform' rating on Amrize (AMRZ) but lowered the price target from $62 to $55. This indicates that while the analyst still sees lo…
Sep 9, 2026
Corporate Catalyst
Bearish
Impact 65
Wells Fargo Downgrades Amrize to Equal-Weight, Lowers Price Target to $44
Wells Fargo analyst Timna Tanners downgraded Amrize (AMRZ) from 'Overweight' to 'Equal-Weight' and lowered the price target from $55 to $44. This action indicates a revised, less o…
Sep 2, 2026
Corporate Catalyst
Bearish
Impact 65
JP Morgan Downgrades Amrize to Neutral, Lowers Price Target to $52
JP Morgan analyst Adrian Huerta downgraded Amrize (AMRZ) from Overweight to Neutral and lowered the price target from $57 to $52. This action indicates a revised, less optimistic v…
Sep 2, 2026
Corporate Catalyst
Bearish
Impact 65
B of A Securities Downgrades Amrize to Underperform, Lowers Price Target to $40
BofA Securities analyst Arnaud Lehmann downgraded Amrize (AMRZ) from Neutral to Underperform and lowered the price target from $50 to $40. This action indicates a revised, more pes…
Aug 25, 2026
Corporate Catalyst
Neutral
Impact 55
DA Davidson Initiates Coverage On Amrize with Neutral Rating, Announces Price Target of $50
DA Davidson's initiation of coverage on Amrize with a Neutral rating and a $50 price target provides a new data point for investors. This is a moderate catalyst as it introduces a …
Aug 24, 2026
Corporate Catalyst
Neutral
Impact 65
Amrize Appoints Samuel J. Poletti CFO, Effective Immediately, Succeeding Baris Oran
Amrize has appointed Samuel J. Poletti as its new CFO, replacing Baris Oran who is departing for personal reasons. This is a significant leadership change in a critical executive p…
Aug 10, 2026
Corporate Catalyst
Bearish
Impact 75
RBC Capital Downgrades Amrize to Underperform, Lowers Price Target to $48
RBC Capital analyst Anthony Codling downgraded Amrize (AMRZ) from 'Sector Perform' to 'Underperform' and significantly lowered the price target from $60 to $48. This action indicat…
Aug 7, 2026
Corporate Catalyst
Bearish
Impact 75
Amrize shares are trading lower after the company reported mixed Q2 financial results.
This headline directly impacts Amrize (AMRZ) as it reflects immediate investor reaction to their Q2 earnings. 'Mixed results' often mean some metrics beat expectations while others…
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 75
Amrize shares are trading lower after the company reported mixed Q2 financial results.
The headline indicates a direct corporate catalyst impacting Amrize. 'Mixed' results often mean some metrics beat expectations while others missed, leading to investor uncertainty …
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 92
Amrize Q2 Adj. EPS $0.88 Misses $0.94 Estimate, Sales $3.494B Beat $3.365B Estimate
Amrize's Q2 earnings report presents a mixed picture. While the company successfully beat revenue expectations, indicating strong top-line growth, the miss on adjusted EPS suggests…
Jul 21, 2026
Corporate Catalyst
Bearish
Impact 55
Oppenheimer Maintains Outperform on Amrize, Lowers Price Target to $65
Oppenheimer analyst Bryan Blair maintained an 'Outperform' rating on Amrize (AMRZ) but lowered the price target from $68 to $65. This action signals that while the analyst still be…
Jul 20, 2026
Corporate Catalyst
Neutral
Impact 55
Amrize Enters Agreement To Acquire Rapid Redi-Mix; Terms Not Disclosed
This acquisition is a corporate catalyst primarily affecting the construction materials sector. While the terms are undisclosed, Amrize (AMRZ) is likely to benefit from increased m…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.